{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CROHN%27S+DISEASE&page=7", "query": { "condition": "CROHN'S DISEASE", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 685, "total_pages": 69, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CROHN%27S+DISEASE&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CROHN%27S+DISEASE&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T13:41:52.332Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04232553", "title": "A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Mirikizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 996, "start_date": "2020-06-22", "completion_date": "2028-03", "has_results": true, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 54, "location_summary": "Dothan, Alabama • Litchfield Park, Arizona • Phoenix, Arizona + 49 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Gilroy", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04232553" }, { "nct_id": "NCT00621257", "title": "Vitamin D Levels in Children With IBD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis" ], "interventions": [ { "name": "ergocalciferol", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cholecalciferol", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "5 Years to 21 Years" }, "enrollment_count": 134, "start_date": "2008-01", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2017-03-22", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621257" }, { "nct_id": "NCT03840928", "title": "PatientSpot Formerly Known as ArthritisPower", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Fibromyalgia", "Gout", "Crohn Disease", "Juvenile Idiopathic Arthritis", "Lupus Erythematosus", "Myositis", "Osteoarthritis", "Osteoporosis", "Psoriasis", "Psoriatic Arthritis", "Scleroderma", "Dermatomyositis", "Inflammatory Bowel Diseases", "Polymyositis", "Axial Spondyloarthritis", "Diffuse Idiopathic Skeletal Hyperostosis", "Polymyalgia Rheumatica", "Giant Cell Arteritis", "Temporal Arteritis", "Wegener", "Relapsing Polychondritis", "Undifferentiated Connective Tissue Disease", "Spinal Cord Injuries", "Alzheimer Disease", "Amyotrophic Lateral Sclerosis", "Ataxia", "Bell Palsy", "Brain Tumor", "Cerebral Aneurysm", "Epilepsy", "Guillain-Barre Syndrome", "Headache", "Head Injury", "Hydrocephalus", "Lumbar Disc Disease", "Meningitis", "Multiple Sclerosis", "Muscular Dystrophy", "Neurocutaneous Syndromes", "Parkinson Disease", "Stroke", "Cluster Headache", "Tension-Type Headache", "Chronic Obstructive Pulmonary Disease", "Asthma", "Lung Cancer", "Cystic Fibrosis", "Sleep Apnea", "Eczema", "Alopecia", "Chronic Inflammation", "Unstable Angina", "Heart Attack", "Heart Failure", "Arrythmia", "Valve Heart Disease", "High Blood Pressure", "Congenital Heart Disease", "Peripheral Arterial Disease", "Diabetes", "Chronic Liver Disease", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Global Healthy Living Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40000, "start_date": "2015-04-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 1, "location_summary": "Upper Nyack, New York", "locations": [ { "city": "Upper Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840928" }, { "nct_id": "NCT06495658", "title": "Impact of Prebiotics in Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Crohn Disease", "Ulcerative Colitis" ], "interventions": [ { "name": "Prebiotic", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 70, "start_date": "2024-07-09", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06495658" }, { "nct_id": "NCT05579444", "title": "Systems Biology of Gastrointestinal and Related Diseases", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ulcerative Colitis", "Crohn Disease", "Obesity", "Colon Polyp", "Eosinophilic Esophagitis", "GERD", "Gastro Esophageal Reflux", "Barrett Esophagus", "Esophageal Cancer", "Gastritis", "Gastric Ulcer", "Duodenal Ulcer", "Intestinal Metaplasia", "Gastric Cancer", "Lymphocytic Colitis", "Microscopic Colitis", "Celiac Sprue", "IBS", "Irritable Bowel Syndrome", "SIBO", "NAFLD", "Gallstone Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Viome", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2022-11-11", "completion_date": "2023-11-29", "has_results": false, "last_update_posted_date": "2023-12-15", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 1, "location_summary": "Bothell, Washington", "locations": [ { "city": "Bothell", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05579444" }, { "nct_id": "NCT07677514", "title": "A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "H021 Enteric-coated Tablets Low-dose Group", "type": "DRUG" }, { "name": "H021 Enteric-coated Tablets High-dose Group", "type": "DRUG" }, { "name": "Placebo Group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jiangsu Carephar Pharmaceutical Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 156, "start_date": "2026-07-12", "completion_date": "2027-11-12", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 3, "location_summary": "Hamden, Connecticut • Lighthouse PT, Florida • Orlando, Florida", "locations": [ { "city": "Hamden", "state": "Connecticut" }, { "city": "Lighthouse PT", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07677514" }, { "nct_id": "NCT03677648", "title": "A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "SHR0302", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Reistone Biopharma Company Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 112, "start_date": "2019-05-14", "completion_date": "2021-12-09", "has_results": false, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 6, "location_summary": "Clearwater, Florida • Lake Wales, Florida • Tampa, Florida + 3 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Lake Wales", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Fall River", "state": "Massachusetts" }, { "city": "Wilmington", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03677648" }, { "nct_id": "NCT01276509", "title": "Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "PF-00547659 SC injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 265, "start_date": "2011-04-06", "completion_date": "2015-10-09", "has_results": true, "last_update_posted_date": "2021-06-03", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 69, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • La Jolla, California + 38 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01276509" }, { "nct_id": "NCT03599622", "title": "An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Granulomatous Colitis", "Crohn's Disease", "Crohn's Enteritis", "Granulomatous Enteritis" ], "interventions": [ { "name": "BMS-986165", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 239, "start_date": "2018-07-16", "completion_date": "2023-10-23", "has_results": true, "last_update_posted_date": "2024-07-03", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 52, "location_summary": "Los Angeles, California • Aurora, Colorado • Hamden, Connecticut + 42 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03599622" }, { "nct_id": "NCT06510296", "title": "Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Crohn's Disease", "Ulcerative Colitis", "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Digital Mind Body Intervention mobile application", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2027-07", "completion_date": "2028-09", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-08T13:41:52.332Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06510296" } ] }